FIELD: medicine.
SUBSTANCE: there are presented: a liposomal preparation for the pulmonary delivery, wherein the liposomes a surface of which is modified by at least one polymer specified in a group consisting of terminally hydrophobisated polyvinyl alcohols and chitosan, an encapsulated gene, a method for preparing and a method of treating a pulmonary tissue disease involving the stage of administering the above liposomal preparation into the patient's lung. It has been shown that the liposome modified by terminally hydrophobisated polyvinyl alcohol may be kept on the pulmonary tissue surface for a long time.
EFFECT: high effectiveness of the pulmonary delivery of the claimed liposomal preparation for a relatively short time.
10 cl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| NUCLEIC ACID COMPLEX AND COMPOSITION FOR NUCLEIC ACID DELIVERY | 2008 |
|
RU2465009C2 |
| CARRIER COMPOSITION FOR WELL-TIMED DELIVERY OF NUCLEIC ACIDS | 2008 |
|
RU2476229C2 |
| LIPOSOME SUSPENSION STABILISER AND METHOD FOR PRODUCTION THEREOF | 2013 |
|
RU2529179C1 |
| LIPOSOMAL PHARMACEUTICAL PREPARATION AND METHOD FOR PREPARING IT | 2007 |
|
RU2494729C2 |
| METHOD OF DELIVERING WATER-INSOLUBLE AND POORLY SOLUBLE BIOACTIVE SUBSTANCES AND PHARMACEUTICAL FORM BASED ON IT | 2006 |
|
RU2325151C2 |
| LIPOSOMAL COMPOSITION AND PHARMACEUTICAL COMPOSITION | 2018 |
|
RU2734900C1 |
| PREORAL DELIVERY SYSTEM FOR PROTEIN SUBSTANCE (OPTIONS), PROTECTIVE COATING FOR DELIVERY SYSTEM (OPTIONS) | 2014 |
|
RU2665367C2 |
| IMPROVED LIPOSOMES AND THEIR APPLICATION | 2008 |
|
RU2482837C2 |
| METHOD OF OBTAINING MAGNETOSENSITIVE LIPOSOMES | 2007 |
|
RU2357724C1 |
| TUMOUR TREATMENT AGENT AND KIT CONTAINING LIPOSOMAL GEMCITABINE COMPOSITION | 2016 |
|
RU2761620C2 |
